Lucile S.
- Country
- France
- Department
- Pneumology
Research Overview
- Randomized, Double‑Blind Trial of Prednisolone Metasulfobenzoate Sodium vs Placebo in Treatment‑Naïve Adults with Fibrotic Hypersensitivity Pneumonitis (RUBY Study)
- Evaluation of Omalizumab Discontinuation Versus Continuation in Patients with Well-Controlled Severe Allergic Asthma: A Multicenter Randomized Controlled Trial
- Non-Inferiority Trial on Dupilumab Withdrawal Versus Continuation in Patients with Controlled Severe Asthma
Data & Insights
Has run more than one trial at 24 of 52 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in the management and treatment of severe asthma, with particular emphasis on innovative therapeutic approaches and treatment optimization strategies.
- Advanced Asthma Management
- Biologic Therapy Assessment
- Treatment Optimization
Their clinical interests center on evaluating long-term therapeutic strategies for patients with severe respiratory conditions.
Therapeutic Assessment
The investigator focuses on studying the effectiveness of biological treatments in respiratory medicine, particularly examining treatment duration and withdrawal strategies.
- Treatment Duration Studies
- Medication Withdrawal Assessment
- Long-term Disease Control
Their work evaluates optimal treatment periods and maintenance strategies for patients with chronic respiratory conditions.
Clinical Outcomes
The investigator examines disease control parameters and treatment efficacy in severe respiratory conditions, focusing on long-term patient outcomes.
- Disease Control Assessment
- Treatment Response Monitoring
- Patient Outcome Evaluation
Their research interests include analyzing the sustainability of treatment responses in chronic respiratory diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.